The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of germline BRCA status on clinical outcomes of patients with HR+/HER2- early breast cancer.
 
Antonio Marra
Consulting or Advisory Role - AstraZeneca; Menarini Group
Speakers' Bureau - Lilly; Roche
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo; Lilly
 
Serena Perazzo
No Relationships to Disclose
 
Enzo Martino
No Relationships to Disclose
 
Gilda Gaudio
No Relationships to Disclose
 
Grazia Castellano
No Relationships to Disclose
 
Ambra Carnevale Schianca
No Relationships to Disclose
 
Bianca Malagutti
No Relationships to Disclose
 
Elisa Giordano
No Relationships to Disclose
 
Carmen Criscitiello
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Seagen
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca; Lilly; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Pfizer; Roche
 
Paola Zagami
No Relationships to Disclose
 
Mariarosaria Calvello
No Relationships to Disclose
 
Monica Marabelli
No Relationships to Disclose
 
Monica Milano
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Gilead Sciences; Novartis
Travel, Accommodations, Expenses - Gilead Sciences
 
Nadia Bianco
Consulting or Advisory Role - Daiichi Sankyo; Novartis
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences
 
Elena Guerini Rocco
Honoraria - AstraZeneca; Exact Sciences; GlaxoSmithKline; Illumina; Menarini; MSD; Novartis; Roche; SOPHiA Genetics; Thermo Fisher Scientific
 
Sara Gandini
No Relationships to Disclose
 
Elisabetta Munzone
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Exact Sciences; Ipsen; MSD Oncology; Pfizer; Seagen
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; Lilly; Novartis; Pfizer; Pierre Fabre; Roche
 
Aliana Guerrieri-Gonzaga
No Relationships to Disclose
 
Bernardo Bonanni
Expert Testimony - Editree srl
 
Giuseppe Curigliano
Leadership - ESMO; ESMO; ESMO Open; European Society of Breast Cancer Specialists (EUSOMA=
Honoraria - Ellipses Pharma
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Celcuity; Daichi-Sankyo; Exact Sciences; Foundation Medicine; Gilead Sciences; GlaxoSmithKline; Guardant Health; Hengrui Therapeutics; Lilly; Menarini; Merck; Novartis; Pfizer; Roche/Genentech; Samsung; Seagen; Veracyte
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Exact Sciences; Foundation Medicine; Gilead Sciences; Lilly; Menarini; Novartis; Pfizer; Roche/Genentech; Samsung; Seagen
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daichii Sankyo; Pfizer; Roche/Genentech